1-11 of 11
Jaeil Ahn
Close
Sort by
Journal Articles

Teclistamab Demonstrates Clinical Activity in Real-World Patients Ineligible for the Pivotal Majestec-1 Trial

Beth Gordon, Lindsay Fogel, Gaurav Varma, Mateo Mejia Saldarriaga, Jaeil Ahn, Adolfo Aleman, Jessica Caro, Xiaoyi Chen, Jorge Monge, Harsh Parmar, David Kaminetzky, Tibor Moskovits, David S. Siegel, Gareth J. Morgan, Ruben Niesvizky, Noa Biran, Faith E. Davies
Journal: Blood
Blood (2023) 142 (Supplement 1): 4741.
https://doi.org/10.1182/blood-2023-181304
Published: 2023
Journal Articles

Inferior Outcomes of Patients with Quad and Penta-Refractory Multiple Myeloma (MM) Compared to Those of Patients Who Have Been Quad and Penta Exposed

Sarvarinder K Gill, Rashmi Unawane, Shuqi Wang, Adolfo Aleman, Michelle Serna, Fideliza Perez-Manon, Gina Rivieccio, David S. Siegel, David H. Vesole, Harsh Parmar, Jaeil Ahn, Noa Biran
Journal: Blood
Blood (2021) 138 (Supplement 1): 4742.
https://doi.org/10.1182/blood-2021-153556
Published: 2021
Journal Articles

Assessment of Serology after Sars-Cov-2 Vaccine in Allogeneic HCT Recipients

Melissa Baker, Maria Cortes, Jaeil Ahn, Michele L. Donato, Sukhdeep Kaur, Hyung C. Suh, Alison Morawski, Phyllis McKiernan, Amy Einstein, Michele Boonstra, Scott D. Rowley
Journal: Blood
Blood (2021) 138 (Supplement 1): 2900.
https://doi.org/10.1182/blood-2021-145642
Published: 2021
Journal Articles

Impact of Treating Facility on Overall Survival and Treatment in Multiple Myeloma (MM) Using National Cancer Database (NCDB)

Kimberley Doucette, Allison Taylor, Bryan Chan, Xiaoyang Ma, Jaeil Ahn, David H. Vesole, Catherine Lai
Journal: Blood
Blood (2021) 138 (Supplement 1): 2996.
https://doi.org/10.1182/blood-2021-153021
Published: 2021
Journal Articles

Production of Anti-Spike Antibodies in Response to COVID Vaccine in Lymphoma Patients

Alexandra Della Pia, Gee Youn Kim, Jaeil Ahn, Yanzhi Liu, Brittany Lukasik, Anamta Contractor, Amin Krushna, Lakshmi Ayyagari, Michael Koropsak, Lori A. Leslie, Andre H. Goy, Tatyana A. Feldman, Andrew Ip
Journal: Blood
Blood (2021) 138 (Supplement 1): 1347.
https://doi.org/10.1182/blood-2021-151367
Published: 2021
Journal Articles

Impact of Treatment Facility Chracteristics on Patient (Pt) Outcomes in Acute Myeloid Leukemia (AML) Using Data from the National Cancer Database (NCDB)

Allison Taylor, MDMS, Kimberley Doucette, MD MSc, Bryan Chan, MPH, Xiaoyang Ma, MS, Jaeil Ahn, PhD, Catherine Lai, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-139034
Published: 2020
Journal Articles

Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19

Michael Roderick Cook, MD, Kaitlyn C Dykes, MDBS, Katherine White, Jaeil Ahn, PhD, Nathan Cobb, MD, Catherine Lai, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-138941
Published: 2020
Journal Articles

Two Year Update of Phase II Trial of Pembrolizumab, Lenalidomide and Dexamethasone As Post -Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Multiple Myeloma

Meena Bansal, DO, David S. Siegel, Jaeil Ahn, PhD, Rena Feinman, PhD, David H. Vesole, MD PhD, Joshua R Richter, MD, Andrew L. Pecora, MD, Elli Gourna Paleoudis, PhD, Scott D. Rowley, MD, Michele L. Donato, MD, Robert Korngold, PhD, Palka Anand, RN, BSN, CCRP, Laura McBride, RN, BSN, OCN, Kristin Ivanovski, RN, BSN, CCRP, Noa Biran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1911.
https://doi.org/10.1182/blood-2019-125155
Published: 2019
Journal Articles

Severe Infections and Antibiotic Use Negatively Impact Progression Free and Overall Survival of Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Marshall McKenna, MD, Rena Feinman, PhD, Jaeil Ahn, PhD, Shuqi Wang, MSc, Elli Gourna Paleoudis, PhD, David H. Vesole, MD PhD, Stuart L. Goldberg, MD, Jun Chih Wang, MD, Abdul Rehman, MD, Giselle Alexandra Suero-Abreu, MD PhD, Phyllis McKiernan, Michele L. Donato, MD, Scott D. Rowley, MD, David S. Siegel, Noa Biran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5510.
https://doi.org/10.1182/blood-2019-132134
Published: 2019
Journal Articles

Elotuzumab As Post-Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Myeloma

Nikhita Gadi, MDMSc, Linda Schmidt, RN, Jaeil Ahn, PhD, Tianmin Wu, MS, Scott D. Rowley, MD, Elli Gourna Paleoudis, PhD, Michele L. Donato, MD, David H. Vesole, MD PhD, Stuart L. Goldberg, MD, David S. Siegel, Noa Biran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3141.
https://doi.org/10.1182/blood-2019-129504
Published: 2019
Journal Articles

Outcomes for Atypical Hemolytic Uremic Syndrome (aHUS) Treated with Eculizumab: A Single Center Analysis

Julia M Cunningham, MD, Jaeil Ahn, PhD, Catherine Broome, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2331.
https://doi.org/10.1182/blood.V130.Suppl_1.2331.2331
Published: 2017